Alfa Wassermann SpA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alfa Wassermann SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011845
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alfa Wassermann SpA (Alfa Wassermann), a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company offers self meditation products for sore throat, headaches, and muscle and joint pain treatments. It also provides antibiotics used for treatment of diseases such as vascular diseases, deep venous thrombosis and gastrointestinal tract diseases. Alfa Wassermann operates through its offices located in the US, the Netherlands, Mexico, France, Spain, Portugal, China, Poland, Romania, Tunisia and Slovakia. Alfa Wassermann is headquartered in Bologna, Italy.

Alfa Wassermann SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alfa Wassermann SpA, Medical Devices Deals, 2011 to YTD 2017 9
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 12
Partnerships 14
Salix Pharma Enters Into Licensing Agreement With Alfa Wassermann For Rifaximin 14
Link Healthcare Enters Co-Marketing Agreement with Sigma-Tau 16
European Institute of Oncology Enters Into Co-Development Agreement With Sigma Tau Industrie 17
Theravance Enters Into Co-Development Agreement With Alfa Wassermann For Velusetrag 18
a V.I. Pharma Enters into Distribution Agreement with Sigma-Tau for Eurartesim 19
Ezose Sciences Enters Into R&D Agreement With Sigma-Tau Industrie Farmaceutiche 20
Licensing Agreements 21
CVie Therapeutics Enters into Licensing Agreement with Sigma-Tau Industrie 21
Pierre Fabre Labs Enters into Licensing Agreement with Sigma-Tau 22
Sigma-Tau Pharma Enters into Licensing Agreement with Crosscare for Colief 23
Lee’s Pharma HK Enters into Licensing Agreement with Sigma-Tau Industrie Farmaceutiche Riunite 24
CVie Therapeutics to Enter into Licensing Agreement with Sigma-Tau 25
CVie Therapeutics to Enter into Licensing Agreement with RostaQuo 27
Soligenix Expands Licensing Agreement With Sigma-Tau Pharma For orBec 29
Equity Offering 31
RegeneRx BioPharma Completes Registered Direct Offering Of US$1.45 Million 31
Asset Transactions 33
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 33
Jazz Pharma Acquires Defibrotide from Sigma-Tau Pharma for USD250 Million 34
Acquisition 36
Sigma-Tau May Sell Sigma-Tau Pharma 36
Alfa Wassermann Acquires Promefarm 37
Alfa Wassermann SpA – Key Competitors 38
Alfa Wassermann SpA – Key Employees 39
Alfa Wassermann SpA – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Key Facts 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alfa Wassermann SpA, Deals By Therapy Area, 2011 to YTD 2017 8
Alfa Wassermann SpA, Medical Devices Deals, 2011 to YTD 2017 9
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 12
Salix Pharma Enters Into Licensing Agreement With Alfa Wassermann For Rifaximin 14
Link Healthcare Enters Co-Marketing Agreement with Sigma-Tau 16
European Institute of Oncology Enters Into Co-Development Agreement With Sigma Tau Industrie 17
Theravance Enters Into Co-Development Agreement With Alfa Wassermann For Velusetrag 18
a V.I. Pharma Enters into Distribution Agreement with Sigma-Tau for Eurartesim 19
Ezose Sciences Enters Into R&D Agreement With Sigma-Tau Industrie Farmaceutiche 20
CVie Therapeutics Enters into Licensing Agreement with Sigma-Tau Industrie 21
Pierre Fabre Labs Enters into Licensing Agreement with Sigma-Tau 22
Sigma-Tau Pharma Enters into Licensing Agreement with Crosscare for Colief 23
Lee’s Pharma HK Enters into Licensing Agreement with Sigma-Tau Industrie Farmaceutiche Riunite 24
CVie Therapeutics to Enter into Licensing Agreement with Sigma-Tau 25
CVie Therapeutics to Enter into Licensing Agreement with RostaQuo 27
Soligenix Expands Licensing Agreement With Sigma-Tau Pharma For orBec 29
RegeneRx BioPharma Completes Registered Direct Offering Of US$1.45 Million 31
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 33
Jazz Pharma Acquires Defibrotide from Sigma-Tau Pharma for USD250 Million 34
Sigma-Tau May Sell Sigma-Tau Pharma 36
Alfa Wassermann Acquires Promefarm 37
Alfa Wassermann SpA, Key Competitors 38
Alfa Wassermann SpA, Key Employees 39
Alfa Wassermann SpA, Other Locations 40
Alfa Wassermann SpA, Subsidiaries 40

★海外企業調査レポート[Alfa Wassermann SpA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QRxPharma Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' QRxPharma Limited Mergers and A …
  • eNeura Therapeutics LLC:(医療機器分野)企業M&A及び提携動向
    Summary eNeura Therapeutics LLC (eNeura) is a medical technology company. The company designs and develops transcranial magnetic stimulation devices for treatment of migraine. Its total migraine system device is placed at the back of the head for less than a minute, which generates single magnetic p …
  • General Plastic Industrial Co., Ltd. (6128):企業財務及び戦略的SWOT分析
    Summary General Plastic Industrial Co., Ltd. (General Plastic Industrial) is a chemical company that designs and manufactures copier and laser printer toner cartridges. The company’s products comprise multi-function toner cartridges for digital machine, toner cartridges for laser printers, copier to …
  • Core Corporation (2359):企業概要、財務及び戦略的SWOT分析
    Summary Core Corporation (Core) is an information technology service provider. The company provides products, solutions and services for information technology industry. It offers products such as trial cloud kit, M2M cloud environment package, M2M platform Revivetally, health care solution and agri …
  • Puma Energy International B.V.:企業のM&A・提携動向(石油・ガス分野)
    Summary Puma Energy International B.V. (Puma) is a midstream and downstream energy company that acquires, refines, stores, transports, and distributes oil products. It owns and operates high-end infrastructure across the world. The company also leases storage capacity to third parties, besides suppo …
  • IBERIABANK Corporation:企業のM&A・提携・投資分析
    IBERIABANK Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IBERIABANK Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Heroux-Devtek Inc.:企業の戦略・SWOT・財務情報
    Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report Summary Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tanzania Electric Supply Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Tanzania Electric Supply Co Ltd (TANESCO), formerly Tanganyika Electric Supply Co Ltd, is a government-owned integrated power company. The company’s operations are regulated by the Ministry of Energy and Minerals. It generates, transmits, distributes and supplies electricity. TANESCO generat …
  • Pretoria Portland Cement Company Limited:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Pretoria Portland Cement Company Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Ti …
  • Union Gas Limited (UNG.PR.C):企業のM&A・提携動向(石油・ガス分野)
    Summary Union Gas Limited (Union Gas), a subsidiary of Spectra Energy Corp, is a natural gas storage, transmission and distribution company. Union Gas’s distribution service area extends across Ontario from the Manitoba border to the North Bay in Muskoka area, through Windsor to west of Toronto, and …
  • ConocoPhillips (COP):電力:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Bank of Taiwan:企業の戦略・SWOT・財務分析
    SummaryBank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Nichicon Corporation (6996):企業財務及び戦略的SWOT分析
    Summary Nichicon Corporation (Nichicon) is an electrical equipment company that offers capacitors, power storage and source systems, and related products. The company offers products such as conductive polymer aluminum solid electrolytic capacitors, aluminum electrolytic capacitors, plastic film cap …
  • Jiangsu Expressway Company Limited (600377):企業財務及び戦略的SWOT分析
    Summary Jiangsu Expressway Company Limited (JEC) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers geographical services, express bus services, service area development, toll roa …
  • Elos Medtech AB (ELOS B):医療機器:M&Aディール及び事業提携情報
    Summary Elos Medtech AB (Elos Medtech) is a partner in development and manufacturer of medical devices and components. The company’s products include dental and orthopedic implants and instruments. It offers diagnostic devices used in the treatment of diabetes, neurosurgery, heart surgery and hearin …
  • VendTek Systems Inc. (VSI):企業概要、財務及び戦略的SWOT分析
    Summary VendTek Systems Inc. (VendTek) is a transaction processing service provider. The company develops, markets and licenses automated transaction system software and support technologies for the prepaid telecom and financial services industries. It offers e-Fresh software, a suite of transaction …
  • Haitong Securities Co., Ltd.:企業のM&A・提携・投資分析
    Haitong Securities Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Haitong Securities Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Avacta Group Plc (AVCT):製品パイプライン分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is …
  • Helix BioMedix Inc:企業の戦略的SWOT分析
    Helix BioMedix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bolu Cimento Sanayii A.S.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bolu Cimento Sanayii A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆